These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12880509)

  • 21. [Psychopharmacological drugs in childhood (author's transl)].
    Groh C; Rosenmayr F
    Padiatr Padol; 1982; 17(2):319-28. PubMed ID: 7099685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
    Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
    Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A theoretical approach to medication adherence for children and youth with psychiatric disorders.
    Charach A; Volpe T; Boydell KM; Gearing RE
    Harv Rev Psychiatry; 2008; 16(2):126-35. PubMed ID: 18415884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
    Harpaz-Rotem I; Rosenheck RA
    Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mother-child interaction and externalizing disorders in elementary schoolchildren].
    Trautmann-Villalba P; Gerhold M; Polowczyk M; Dinter-Jörg M; Laucht M; Esser G; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2001 Nov; 29(4):263-73. PubMed ID: 11763606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention-deficit/hyperactivity disorder and callous-unemotional traits as moderators of conduct problems when examining impairment and aggression in elementary school children.
    Waschbusch DA; Willoughby MT
    Aggress Behav; 2008; 34(2):139-53. PubMed ID: 17696164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between hospitalization for pharmaceutical ingestion and attention deficit disorder in children aged 5 to 9 years old.
    Hariharan S; Pomerantz W
    Clin Pediatr (Phila); 2008 Jan; 47(1):15-20. PubMed ID: 17641117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric psychopharmacology in a capitated managed care system: how do patients fare?
    Bastiaens L
    J Child Adolesc Psychopharmacol; 1998; 8(2):115-24. PubMed ID: 9730077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bipolar disorders as co-morbidity in childhood and adolescence--underdiagnosed or overinterpreted? Therapy of a 14-year-old boy with hyperkinetic conduct disorder and hypomania].
    Rothermel B; Poustka L; Banaschewski T; Becker K
    Z Kinder Jugendpsychiatr Psychother; 2010 Mar; 38(2):123-9; quiz 130. PubMed ID: 20200829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oppositional defiant disorder symptoms in relation to psychopathic traits and aggression among psychiatrically hospitalized children: ADHD symptoms as a potential moderator.
    Becker SP; Luebbe AM; Fite PJ; Greening L; Stoppelbein L
    Aggress Behav; 2013; 39(3):201-11. PubMed ID: 23436456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychopharmacologic strategies for the treatment of aggression in juveniles.
    Steiner H; Saxena K; Chang K
    CNS Spectr; 2003 Apr; 8(4):298-308. PubMed ID: 12679744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotropic utilization and psychiatric presentation of hospitalized very young children.
    Pathak S; Arszman SP; Danielyan A; Johns ES; Smirnov A; Kowatch RA
    J Child Adolesc Psychopharmacol; 2004; 14(3):433-42. PubMed ID: 15650500
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychoactive substance use among patients admitted to an acute psychiatric ward: laboratory findings and associations with clinical characteristics.
    Mordal J; Holm B; Gossop M; Romøren M; Mørland J; Bramness J
    Nord J Psychiatry; 2011 Jun; 65(3):208-15. PubMed ID: 21047195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cholesterol and aggressive behavior in psychiatrically hospitalized children.
    Rao U; Carlson GA; Rapport MD
    Acta Psychiatr Scand; 1991 Jan; 83(1):77-8. PubMed ID: 2011960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effectiveness of carbamazepine and propranolol for rage outbursts.
    Mattes JA
    J Neuropsychiatry Clin Neurosci; 1990; 2(2):159-64. PubMed ID: 2136070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral disinhibition and antiepileptic treatment in childhood epilepsy: A retrospective cohort study.
    van Tuijl DC; Groenwold RHH; Vlaskamp C; van Campen JS; Braun KPJ; Jansen FE; Bruining H
    Epilepsia Open; 2017 Mar; 2(1):59-66. PubMed ID: 29750213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.